Literature DB >> 31505086

Sensory dysregulation in tic disorders is associated with executive dysfunction and comorbidities.

Nicolette Soler1,2, Chris Hardwick1, Iain E Perkes1,2,3, Shekeeb S Mohammad4,2, David Dossetor1,2, Kenneth Nunn1,2, Paula Bray5, Russell C Dale4,2,6.   

Abstract

BACKGROUND: Tics are conceptualized as a sensorimotor phenomenon with a premonitory urge typically described by patients. As observed in other neurodevelopmental disorders, we have observed sensory dysregulation symptoms, such as tactile hypersensitivity to clothing, in children with tic disorders; however, formal clinical research in this area is limited.
OBJECTIVE: To define the presence of sensory dysregulation symptoms in tic disorders, and their clinical associations.
METHODS: Prevalence of sensory dysregulation in 102 children with tic disorders was compared to 61 age- and sex-matched healthy controls. Sensory dysregulation, executive function, and quality of life data were obtained through the Short Sensory Profile-2, Sensory Profile-2, Sensory Processing Measure, Behaviour Rating Inventory of Executive Function-2, and Strength and Difficulties Questionnaire and Pediatric Quality of Life Inventory. Tics were assessed with the Yale Global Tic Severity Scale.
RESULTS: Children with tics, in the presence of comorbidity, had elevated sensory dysregulation compared to healthy controls (P < 0.001). There was a positive correlation between sensory dysregulation and global executive difficulties in children with tics and comorbidity (n = 87; rho = 0.716; P < 0.001) and a negative correlation of sensory dysregulation with quality of life (n = 87; rho = -0.595; P < 0.001). In children with tics, there was an association between sensory dysregulation and number of comorbidities (P < 0.001).
CONCLUSION: In the presence of comorbidity, children with tic disorders have broad sensory dysregulation symptoms beyond the premonitory urge. There was a statistically significant association between sensory dysregulation and executive function difficulties and the presence of neurodevelopmental and psychiatric comorbidity. Sensory dysregulation can be considered neurodevelopmental symptoms, providing insight into the neurobiology of tics and opportunities for therapeutic intervention.
© 2019 International Parkinson and Movement Disorder Society. © 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  child; executive dysfunction; neurodevelopmental disorders; sensory dysregulation; tic disorders

Mesh:

Year:  2019        PMID: 31505086     DOI: 10.1002/mds.27817

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Cross-disorder comparison of sensory over-responsivity in chronic tic disorders and obsessive-compulsive disorder.

Authors:  David Isaacs; Alexandra P Key; Carissa J Cascio; Alexander C Conley; Heather Riordan; Harrison C Walker; Mark T Wallace; Daniel O Claassen
Journal:  Compr Psychiatry       Date:  2021-12-17       Impact factor: 3.735

2.  Tic Disorder of Children Analyzed and Diagnosed by Magnetic Resonance Imaging Features under Convolutional Neural Network.

Authors:  Chunxia Wu; Qingerile Si; Budegerile Su; Lan Mu; Gaowa Bao; Musiguleng Ji; Daohu Ao
Journal:  Contrast Media Mol Imaging       Date:  2021-11-11       Impact factor: 3.161

3.  Sensory Processing Phenotypes in Phelan-McDermid Syndrome and SYNGAP1-Related Intellectual Disability.

Authors:  Ariel M Lyons-Warren; Maria C McCormack; Jimmy L Holder
Journal:  Brain Sci       Date:  2022-01-20

4.  Effect of Short-Term Deep-Pressure Portable Seat on Behavioral and Biological Stress in Children with Autism Spectrum Disorders: A Pilot Study.

Authors:  Ilham Yustar Afif; Muhammad Farkhan; Ojo Kurdi; Mohamad Izzur Maula; Muhammad Imam Ammarullah; Budi Setiyana; J Jamari; Tri Indah Winarni
Journal:  Bioengineering (Basel)       Date:  2022-01-20

5.  Sensory Hypersensitivity Severity and Association with Obsessive-Compulsive Symptoms in Adults with Tic Disorder.

Authors:  David Isaacs; Alexandra P Key; Carissa J Cascio; Alexander C Conley; Harrison C Walker; Mark T Wallace; Daniel O Claassen
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-02       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.